Abrams PP, Cardozo LL, Fall MM, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49. doi:10.1016/S0090-4295(02)02243-4.
Article
PubMed
Google Scholar
Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760–6. doi:10.1046/j.1464-410x.2001.02228.x.
Article
CAS
PubMed
Google Scholar
Chancellor MB, Yoshimura N. Neurophysiology of stress urinary incontinence. Rev Urol. 2004;6 Suppl 3:S19–28.
PubMed Central
PubMed
Google Scholar
Fetscher C, Fleichman M, Schmidt M, Krege S, Michel MC. M 3muscarinic receptors mediate contraction of human urinary bladder. Br J Pharmacol. 2002;136(5):641–4. doi:10.1038/sj.bjp.0704781.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chu FM, Dmochowski R. Pathophysiology of overactive bladder. Am J Med. 2006;119(3 Suppl 1):6–6. doi:10.1016/j.amjmed.2005.12.010. Thorough overview of the pathophysiology of overactive bladder.
Google Scholar
Murphy AM, Krlin RM, Goldman HB. Treatment of overactive bladder: what is on the horizon? Int Urogynecol J. 2013;24(1):5–13. doi:10.1007/s00192-012-1860-6. Overview of current and arising treatments for overactive bladder.
Article
PubMed
Google Scholar
Aizawa N, Igawa Y, Nishizawa O, Wyndaele J-J. Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn. 2010;29(5):771–6. doi:10.1002/nau.20826.
Article
CAS
PubMed
Google Scholar
Hu TW, Wagner TH. Economic considerations in overactive bladder. Am J Manag Care. 2000;6(11 Suppl):S591–8.
CAS
PubMed
Google Scholar
Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36. doi:10.1007/s00345-002-0301-4.
CAS
PubMed
Google Scholar
Kay GG, Abou-Donia MB, Messer WS, Murphy DG, Tsao JW, Ouslander JG. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc. 2005;53(12):2195–201. doi:10.1111/j.1532-5415.2005.00537.x.
Article
PubMed
Google Scholar
Thom DH, Haan MN, Van Den Eeden SK. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing. 1997;26(5):367–74. doi:10.1093/ageing/26.5.367.
Article
CAS
PubMed
Google Scholar
Benner JS, Nichol MB, Rovner ES, et al. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010;105(9):1276–82. doi:10.1111/j.1464-410X.2009.09036.x.
Article
PubMed
Google Scholar
Rees AM. The Complementary and Alternative Medicine Information Source Book. ABC-CLIO; 2001.
Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;343:1–19.
PubMed
Google Scholar
Chughtai B, Kavaler E, Lee R, Te A, Kaplan SA, Lowe F. Use of herbal supplements for overactive bladder. Rev Urol. 2013;15(3):93. Great overview of commonly used herbal supplements used to treat OAB.
PubMed Central
PubMed
Google Scholar
Gotoh A, Goto K, Sengoku A, et al. Inhibition of urinary bladder motility by a spinal action of U-50488H in rats. J Pharm Pharmacol. 2002;54(12):1645–50. doi:10.1211/002235702397.
Article
CAS
PubMed
Google Scholar
Omiya Y, Suzuki Y, Yuzurihara M, Murata M. Antinociceptive effect of Shakuyakukanzoto, a Kampo Medicine, in Diabetic Mice. Journal of …. 2005.
Gotoh A, Goto K, Sengoku A, et al. Inhibition mechanism of Gosha-jinki-gan on the micturition reflex in rats. J Pharmacol Sci. 2004;96(2):115–23.
Article
CAS
PubMed
Google Scholar
Suzuki T, Higashi H, Saitoh K, Kurokawa K, Ohma C, Yamanaka H. Effects of gosha-jinki-gan on urinary bladder contraction in dogs. Hinyokika Kiyo. 1997;43(4):271–4.
CAS
PubMed
Google Scholar
Ogushi T, Takahashi S. Effect of Chinese herbal medicine on overactive bladder. Hinyokika Kiyo. 2007;53(12):857–62.
PubMed
Google Scholar
Kajiwara M, Mutaguchi K. Clinical efficacy and tolerability of gosha-jinki-gan, Japanese traditional herbal medicine, in females with overactive bladder. Hinyokika Kiyo. 2008;54(2):95–9.
PubMed
Google Scholar
Ito Y, Seki M, Nishioka Y, et al. Pharmacological effects of Hachi-mi-jio-gan extract (Harncare) on the contractile response and on pharmacologically relevant receptors in the rat bladder. Yakugaku Zasshi. 2009;129(8):957–64. doi:10.1248/yakushi.129.957.
Article
CAS
PubMed
Google Scholar
Yoshimura K, Terai A, Arai Y. Two-week administration of low-dose Hachimi-jio-gan (Ba-Wei Di-Huang-Wan) for patients with benign prostatic hyperplasia. Hinyokika Kiyo. 2003;49(9):509–14.
PubMed
Google Scholar
Liu J, Kurashiki K, Shimizu K, Kondo R. 5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum. Biol Pharm Bull. 2006;29(2):392–5.
Article
PubMed
Google Scholar
Noguchi M, Kakuma T, Tomiyasu K, et al. Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging study. Asian J Androl. 2008;10(4):651–8. doi:10.1111/j.1745-7262.2008.00336.x.
Article
PubMed
Google Scholar
Chancellor MB, de Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol. 1999;162(1):3–11. doi:10.1097/00005392-199907000-00002.
Article
CAS
PubMed
Google Scholar
Lazzeri M, Beneforti P, Spinelli M, Zanollo A, Barbagli G, Turini D. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol. 2000;164(3 Pt 1):676–9.
Article
CAS
PubMed
Google Scholar
Saitoh C, Chancellor MB, de Groat WC, Yoshimura N. Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving. Conscious rats. J Urol. 2008;179(1):359–64. doi:10.1016/j.juro.2007.08.090.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ojiako OA, Igwe CU. Nutritional and anti-nutritional compositions of Cleome rutidosperma, Lagenaria siceraria, and Cucurbita maxima seeds from Nigeria. J Med Food. 2007;10(4):735–8. doi:10.1089/jmf.2007.625.
Article
CAS
PubMed
Google Scholar
Hata K, Tanahashi S, Wakida Y, Tatsuzaki M, Koide A. Hata: Effects of pumpkin seed extract on urinary… - Google Scholar. Med Sci …. 2005.
Friederich M, Theurer C, Schiebel-Schlosser G. Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients. Forsch Komplementarmed Klass Naturheilkd. 2000;7(4):200–4.
Article
CAS
PubMed
Google Scholar
Nishimura M, Ohkawara T, Sato H, Takeda H, Nishihira J. Pumpkin seed oil extracted from Cucurbita maxima improves urinary disorder in human overactive bladder. J Tradit Complement Med. 2014;4(1):72–4. doi:10.4103/2225-4110.124355.
Article
PubMed Central
PubMed
Google Scholar
Paik S-H, Han S-R, Kwon O-J, Ahn Y-M, Lee B-C, Ahn S-Y. Acupuncture for the treatment of urinary incontinence: a review of randomized controlled trials. Exp Ther Med. 2013;6(3):773–80. doi:10.3892/etm.2013.1210. Overview of randomized control trials to date of acupuncture use for incontinence with in-depth review of their study designs, results, and limitations.
PubMed Central
PubMed
Google Scholar
Emmons SL, Otto L. Acupuncture for overactive bladder: a randomized controlled trial. Obstet Gynecol. 2005;106(1):138–43. doi:10.1097/01.AOG.0000163258.57895.ec.
Article
PubMed
Google Scholar
Kelleher CJ, Filshie J, Burton G, Khullar V, Cardozo LD. Acupuncture and the treatment of irritative bladder symptoms. Acupunct Med. 1994;12(1):9–12. doi:10.1136/aim.12.1.9.
Article
Google Scholar
Engberg S, Cohen S, Sereika SM. The efficacy of acupuncture in treating urge and mixed incontinence in women: a pilot study. J Wound Ostomy Continence Nurs. 2009;36(6):661–70. doi:10.1097/WON.0b013e3181bd82dd.
Article
PubMed
Google Scholar
Chernin D. The Complete Homeopathic Resource for Common Illnesses. North Atlantic Books; 2006.
Gollmann W. The Homoeopathic Guide in All Diseases of the Urinary and Sexual Organs. 1855.
van Leeuwen JHS, Castro R, Busse M, Bemelmans BL. The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms. Eur Urol. 2006;50(3):440–53. doi:10.1016/j.eururo.2006.05.014.
Article
PubMed
Google Scholar